Acima Private Wealth’s Edwards Lifesciences EW Stock Holding History

Acima Private Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$464K	Sell	5,373 -531	-9%	-$47.2K	0.13%	78
2026 Q2	$534K	Hold	5,904	–	–	0.16%	74
2026 Q1	$473K	Hold	5,904	–	–	0.15%	75
2025 Q4	$503K	Hold	5,904	–	–	0.16%	74
2025 Q3	$459K	Hold	5,904	–	–	0.14%	76
2025 Q2	$462K	Hold	5,904	–	–	0.16%	74
2025 Q1	$428K	Hold	5,904	–	–	0.15%	77
2024 Q4	$437K	Hold	5,904	–	–	0.15%	82
2024 Q3	$390K	Hold	5,904	–	–	0.13%	90
2024 Q2	$545K	Hold	5,904	–	–	0.2%	72
2024 Q1	$564K	Hold	5,904	–	–	0.21%	76
2023 Q4	$450K	Hold	5,904	–	–	0.18%	85
2023 Q3	$409K	Hold	5,904	–	–	0.18%	93
2023 Q2	$557K	Sell	5,904 -162	-3%	-$14.1K	0.27%	78
2023 Q1	$502K	Hold	6,066	–	–	0.25%	81
2022 Q4	$453K	Hold	6,066	–	–	0.23%	83
2022 Q3	$501K	Hold	6,066	–	–	0.26%	71
2022 Q2	$577K	Hold	6,066	–	–	0.29%	68
2022 Q1	$714K	Hold	6,066	–	–	0.33%	69
2021 Q4	$786K	Hold	6,066	–	–	0.34%	71
2021 Q3	$687K	Hold	6,066	–	–	0.32%	74
2021 Q2	$628K	Hold	6,066	–	–	0.29%	76
2021 Q1	$507K	Hold	6,066	–	–	0.25%	78
2020 Q4	$553K	Hold	6,066	–	–	0.29%	77
2020 Q3	$484K	Hold	6,066	–	–	0.29%	78
2020 Q2	$419K	Hold	6,066	–	–	0.27%	79
2020 Q1	$381K	Hold	6,066	–	–	0.29%	78
2019 Q4	$472K	Hold	6,066	–	–	0.33%	75
2019 Q3	$444K	Hold	6,066	–	–	0.34%	72
2019 Q2	$374K	Hold	6,066	–	–	0.3%	78
2019 Q1	$387K	Hold	6,066	–	–	0.33%	71
2018 Q4	$310K	Buy	+6,066	New	+$307K	0.3%	78

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Ninety One Cape Town, South Africa $2B AUM 34.6% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $532M AUM 7.98% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Acima Private Wealth's EW Position: Q3 2026 in Review

Acima Private Wealth reduced its Edwards Lifesciences (EW) stake by 9% in Q3 2026, selling an estimated $47.2K and leaving 5,373 shares worth $464K. The position accounts for 0.13% of the portfolio, ranked #78.

Acima Private Wealth first reported a position in EW in Q4 2018 and has held it in 32 quarters since. The position peaked at $786K in Q4 2021. 135 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Acima Private Wealth held 5,373 shares of Edwards Lifesciences worth $464K as of Q3 2026.
Acima Private Wealth sold 531 Edwards Lifesciences shares in Q3 2026, an estimated $47.2K.
Edwards Lifesciences made up 0.13% of Acima Private Wealth's portfolio in Q3 2026, its #78 holding.
Acima Private Wealth first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 32 quarters since.
Acima Private Wealth's Edwards Lifesciences position peaked at $786K in Q4 2021.
135 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Acima Private Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.